Global Polio Vaccine Supply, Demand and Key Producers, 2026-2032
The global Polio Vaccine market size is expected to reach $ 1950 million by 2032, rising at a market growth of 4.1% CAGR during the forecast period (2026-2032).
Polio vaccine is a preventive biological product used to prevent poliovirus infection and the risk of acute flaccid paralysis caused by poliomyelitis. It mainly includes injectable Inactivated Polio Vaccine, Oral Polio Vaccine, Sabin-strain Inactivated Polio Vaccine, and multivalent combination vaccines containing polio antigen components. By inducing active immunity against polioviruses, these products protect individuals while helping maintain population-level immune barriers, reduce transmission, and prevent importation risks. Based on technology route, IPV emphasizes safety and long-term protection in the post-eradication stage, OPV emphasizes intestinal mucosal immunity, rapid coverage, and transmission interruption, while combination vaccines improve pediatric vaccination convenience and immunization program efficiency. Polio vaccines combine public health necessity, national strategic reserve value, and high technical barriers, making them one of the most important vaccine categories in the global polio eradication agenda.In 2025, global Polio vaccine production reached approximately 785 million units.The average gross profit margin of this product is 70%.
The market opportunities for polio vaccines are driven by the final stage of global polio eradication, continuous upgrading of immunization programs, and rising vaccine safety requirements. As countries optimize the use structure of OPV and IPV, the polio vaccine market is no longer a single low-price public health category. Instead, it has formed a multilayer product system in which IPV strengthens the safety foundation, OPV interrupts transmission, combination vaccines improve vaccination experience, and novel OPV enhances emergency response. China?s current immunization strategy adopts a sequential schedule of IPV and bOPV, showing that policymakers value both the safety of inactivated vaccines and the herd-immunity role of oral vaccines. WHO prequalification of novel oral polio vaccines further strengthens the global emergency supply system. For manufacturers, polio vaccines represent a strategic product platform connected to national immunization programs, international organization procurement, domestic substitution, combination vaccine upgrading, and global public health cooperation.
The industry?s challenges are concentrated in policy transition, quality regulation, biosafety, and supply stability. OPV has strong transmission-interruption advantages, but because it contains live attenuated virus and carries vaccine-derived virus risks, its routine-use space will gradually adjust as global polio eradication progresses. IPV has a stronger safety profile, but its manufacturing process is more complex and cost-intensive, requiring high standards for cell culture, virus purification, inactivation validation, and antigen consistency. Combination vaccines involve even higher barriers, including multi-antigen compatibility, immune interference, adjuvant systems, and clinical validation. Because polio vaccines are administered to children and used in public health systems, regulators impose strict requirements on registration approval, GMP, batch release, cold-chain traceability, and post-marketing surveillance. Companies lacking stable capacity, international certification, and mature quality systems will find it difficult to build long-term advantages in government procurement and global supply systems.
Downstream demand is expanding from basic immunization to sequential vaccination, catch-up vaccination, emergency stockpiling, outbreak control, international aid, and premium combination vaccination. Disease control systems focus on whether product portfolios can balance safety, coverage efficiency, supply stability, and transmission interruption. Vaccination clinics require products with clear dosage forms, stable distribution, convenient operation, and easy parent communication. International organizations and developing-country markets place greater emphasis on accessibility, cold-chain adaptability, and emergency response speed. The self-pay market focuses more on fewer injections and greater convenience delivered by IPV-containing multivalent vaccines. In the future, demand for polio vaccines will no longer be driven only by birth cohorts, but also by global importation risks, immunization strategy adjustments, combination vaccine upgrading, and public health stockpile mechanisms.
This report studies the global Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Polio Vaccine total production and demand, 2021-2032, (K Dose)
Global Polio Vaccine total production value, 2021-2032, (USD Million)
Global Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute (Bilthoven Biologicals), Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Polio Vaccine Market, By Region:
1. How big is the global Polio Vaccine market?
2. What is the demand of the global Polio Vaccine market?
3. What is the year over year growth of the global Polio Vaccine market?
4. What is the production and production value of the global Polio Vaccine market?
5. Who are the key producers in the global Polio Vaccine market?
6. What are the growth factors driving the market demand?
Polio vaccine is a preventive biological product used to prevent poliovirus infection and the risk of acute flaccid paralysis caused by poliomyelitis. It mainly includes injectable Inactivated Polio Vaccine, Oral Polio Vaccine, Sabin-strain Inactivated Polio Vaccine, and multivalent combination vaccines containing polio antigen components. By inducing active immunity against polioviruses, these products protect individuals while helping maintain population-level immune barriers, reduce transmission, and prevent importation risks. Based on technology route, IPV emphasizes safety and long-term protection in the post-eradication stage, OPV emphasizes intestinal mucosal immunity, rapid coverage, and transmission interruption, while combination vaccines improve pediatric vaccination convenience and immunization program efficiency. Polio vaccines combine public health necessity, national strategic reserve value, and high technical barriers, making them one of the most important vaccine categories in the global polio eradication agenda.In 2025, global Polio vaccine production reached approximately 785 million units.The average gross profit margin of this product is 70%.
The market opportunities for polio vaccines are driven by the final stage of global polio eradication, continuous upgrading of immunization programs, and rising vaccine safety requirements. As countries optimize the use structure of OPV and IPV, the polio vaccine market is no longer a single low-price public health category. Instead, it has formed a multilayer product system in which IPV strengthens the safety foundation, OPV interrupts transmission, combination vaccines improve vaccination experience, and novel OPV enhances emergency response. China?s current immunization strategy adopts a sequential schedule of IPV and bOPV, showing that policymakers value both the safety of inactivated vaccines and the herd-immunity role of oral vaccines. WHO prequalification of novel oral polio vaccines further strengthens the global emergency supply system. For manufacturers, polio vaccines represent a strategic product platform connected to national immunization programs, international organization procurement, domestic substitution, combination vaccine upgrading, and global public health cooperation.
The industry?s challenges are concentrated in policy transition, quality regulation, biosafety, and supply stability. OPV has strong transmission-interruption advantages, but because it contains live attenuated virus and carries vaccine-derived virus risks, its routine-use space will gradually adjust as global polio eradication progresses. IPV has a stronger safety profile, but its manufacturing process is more complex and cost-intensive, requiring high standards for cell culture, virus purification, inactivation validation, and antigen consistency. Combination vaccines involve even higher barriers, including multi-antigen compatibility, immune interference, adjuvant systems, and clinical validation. Because polio vaccines are administered to children and used in public health systems, regulators impose strict requirements on registration approval, GMP, batch release, cold-chain traceability, and post-marketing surveillance. Companies lacking stable capacity, international certification, and mature quality systems will find it difficult to build long-term advantages in government procurement and global supply systems.
Downstream demand is expanding from basic immunization to sequential vaccination, catch-up vaccination, emergency stockpiling, outbreak control, international aid, and premium combination vaccination. Disease control systems focus on whether product portfolios can balance safety, coverage efficiency, supply stability, and transmission interruption. Vaccination clinics require products with clear dosage forms, stable distribution, convenient operation, and easy parent communication. International organizations and developing-country markets place greater emphasis on accessibility, cold-chain adaptability, and emergency response speed. The self-pay market focuses more on fewer injections and greater convenience delivered by IPV-containing multivalent vaccines. In the future, demand for polio vaccines will no longer be driven only by birth cohorts, but also by global importation risks, immunization strategy adjustments, combination vaccine upgrading, and public health stockpile mechanisms.
This report studies the global Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Polio Vaccine total production and demand, 2021-2032, (K Dose)
Global Polio Vaccine total production value, 2021-2032, (USD Million)
Global Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute (Bilthoven Biologicals), Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Polio Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Monovalent
- Bivalent
- Trivalent
- Oral Drops
- Sugar Pill
- Injection
- Public
- Private
- Sanofi
- GSK
- Bibcol
- Serum Institute (Bilthoven Biologicals)
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
1. How big is the global Polio Vaccine market?
2. What is the demand of the global Polio Vaccine market?
3. What is the year over year growth of the global Polio Vaccine market?
4. What is the production and production value of the global Polio Vaccine market?
5. Who are the key producers in the global Polio Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Polio Vaccine Introduction
1.2 World Polio Vaccine Supply & Forecast
1.2.1 World Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Polio Vaccine Production (2021-2032)
1.2.3 World Polio Vaccine Pricing Trends (2021-2032)
1.3 World Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Polio Vaccine Production by Region (2021-2032)
1.3.3 World Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Polio Vaccine Production (2021-2032)
1.3.5 Europe Polio Vaccine Production (2021-2032)
1.3.6 China Polio Vaccine Production (2021-2032)
1.3.7 Japan Polio Vaccine Production (2021-2032)
1.3.8 India Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Polio Vaccine Demand (2021-2032)
2.2 World Polio Vaccine Consumption by Region
2.2.1 World Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Polio Vaccine Consumption (2021-2032)
2.4 China Polio Vaccine Consumption (2021-2032)
2.5 Europe Polio Vaccine Consumption (2021-2032)
2.6 Japan Polio Vaccine Consumption (2021-2032)
2.7 South Korea Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Polio Vaccine Consumption (2021-2032)
2.9 India Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Polio Vaccine in 2025
3.6 Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Polio Vaccine Market: Region Footprint
3.6.2 Polio Vaccine Market: Company Product Type Footprint
3.6.3 Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Polio Vaccine Production Comparison
4.2.1 United States VS China: Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Polio Vaccine Production (2021-2026)
4.5 China Based Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Inactivated Polio Vaccine (IPV)
5.2.2 Oral Polio Vaccine (OPV)
5.3 Market Segment by Type
5.3.1 World Polio Vaccine Production by Type (2021-2032)
5.3.2 World Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VIRUS TYPE
6.1 World Polio Vaccine Market Size Overview by Virus Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Virus Type
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.3 Market Segment by Virus Type
6.3.1 World Polio Vaccine Production by Virus Type (2021-2032)
6.3.2 World Polio Vaccine Production Value by Virus Type (2021-2032)
6.3.3 World Polio Vaccine Average Price by Virus Type (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Polio Vaccine Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral Drops
7.2.2 Sugar Pill
7.2.3 Injection
7.3 Market Segment by Dosage Form
7.3.1 World Polio Vaccine Production by Dosage Form (2021-2032)
7.3.2 World Polio Vaccine Production Value by Dosage Form (2021-2032)
7.3.3 World Polio Vaccine Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public
8.2.2 Private
8.3 Market Segment by Application
8.3.1 World Polio Vaccine Production by Application (2021-2032)
8.3.2 World Polio Vaccine Production Value by Application (2021-2032)
8.3.3 World Polio Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Polio Vaccine Product and Services
9.1.4 Sanofi Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Polio Vaccine Product and Services
9.2.4 GSK Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Bibcol
9.3.1 Bibcol Details
9.3.2 Bibcol Major Business
9.3.3 Bibcol Polio Vaccine Product and Services
9.3.4 Bibcol Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bibcol Recent Developments/Updates
9.3.6 Bibcol Competitive Strengths & Weaknesses
9.4 Serum Institute (Bilthoven Biologicals)
9.4.1 Serum Institute (Bilthoven Biologicals) Details
9.4.2 Serum Institute (Bilthoven Biologicals) Major Business
9.4.3 Serum Institute (Bilthoven Biologicals) Polio Vaccine Product and Services
9.4.4 Serum Institute (Bilthoven Biologicals) Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
9.4.6 Serum Institute (Bilthoven Biologicals) Competitive Strengths & Weaknesses
9.5 Tiantan Biological
9.5.1 Tiantan Biological Details
9.5.2 Tiantan Biological Major Business
9.5.3 Tiantan Biological Polio Vaccine Product and Services
9.5.4 Tiantan Biological Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Tiantan Biological Recent Developments/Updates
9.5.6 Tiantan Biological Competitive Strengths & Weaknesses
9.6 IMBCA
9.6.1 IMBCA Details
9.6.2 IMBCA Major Business
9.6.3 IMBCA Polio Vaccine Product and Services
9.6.4 IMBCA Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 IMBCA Recent Developments/Updates
9.6.6 IMBCA Competitive Strengths & Weaknesses
9.7 Panacea Biotec Ltd
9.7.1 Panacea Biotec Ltd Details
9.7.2 Panacea Biotec Ltd Major Business
9.7.3 Panacea Biotec Ltd Polio Vaccine Product and Services
9.7.4 Panacea Biotec Ltd Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Ltd Recent Developments/Updates
9.7.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
9.8 Bio-Med
9.8.1 Bio-Med Details
9.8.2 Bio-Med Major Business
9.8.3 Bio-Med Polio Vaccine Product and Services
9.8.4 Bio-Med Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bio-Med Recent Developments/Updates
9.8.6 Bio-Med Competitive Strengths & Weaknesses
9.9 Halfkin Bio-Pharmaceuticals
9.9.1 Halfkin Bio-Pharmaceuticals Details
9.9.2 Halfkin Bio-Pharmaceuticals Major Business
9.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
9.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
9.9.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Polio Vaccine Industry Chain
10.2 Polio Vaccine Upstream Analysis
10.2.1 Polio Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Polio Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Polio Vaccine Production Mode
10.6 Polio Vaccine Procurement Model
10.7 Polio Vaccine Industry Sales Model and Sales Channels
10.7.1 Polio Vaccine Sales Model
10.7.2 Polio Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Polio Vaccine Introduction
1.2 World Polio Vaccine Supply & Forecast
1.2.1 World Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Polio Vaccine Production (2021-2032)
1.2.3 World Polio Vaccine Pricing Trends (2021-2032)
1.3 World Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Polio Vaccine Production by Region (2021-2032)
1.3.3 World Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Polio Vaccine Production (2021-2032)
1.3.5 Europe Polio Vaccine Production (2021-2032)
1.3.6 China Polio Vaccine Production (2021-2032)
1.3.7 Japan Polio Vaccine Production (2021-2032)
1.3.8 India Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Polio Vaccine Demand (2021-2032)
2.2 World Polio Vaccine Consumption by Region
2.2.1 World Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Polio Vaccine Consumption (2021-2032)
2.4 China Polio Vaccine Consumption (2021-2032)
2.5 Europe Polio Vaccine Consumption (2021-2032)
2.6 Japan Polio Vaccine Consumption (2021-2032)
2.7 South Korea Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Polio Vaccine Consumption (2021-2032)
2.9 India Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Polio Vaccine in 2025
3.6 Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Polio Vaccine Market: Region Footprint
3.6.2 Polio Vaccine Market: Company Product Type Footprint
3.6.3 Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Polio Vaccine Production Comparison
4.2.1 United States VS China: Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Polio Vaccine Production (2021-2026)
4.5 China Based Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Inactivated Polio Vaccine (IPV)
5.2.2 Oral Polio Vaccine (OPV)
5.3 Market Segment by Type
5.3.1 World Polio Vaccine Production by Type (2021-2032)
5.3.2 World Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VIRUS TYPE
6.1 World Polio Vaccine Market Size Overview by Virus Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Virus Type
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.3 Market Segment by Virus Type
6.3.1 World Polio Vaccine Production by Virus Type (2021-2032)
6.3.2 World Polio Vaccine Production Value by Virus Type (2021-2032)
6.3.3 World Polio Vaccine Average Price by Virus Type (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Polio Vaccine Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral Drops
7.2.2 Sugar Pill
7.2.3 Injection
7.3 Market Segment by Dosage Form
7.3.1 World Polio Vaccine Production by Dosage Form (2021-2032)
7.3.2 World Polio Vaccine Production Value by Dosage Form (2021-2032)
7.3.3 World Polio Vaccine Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public
8.2.2 Private
8.3 Market Segment by Application
8.3.1 World Polio Vaccine Production by Application (2021-2032)
8.3.2 World Polio Vaccine Production Value by Application (2021-2032)
8.3.3 World Polio Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Polio Vaccine Product and Services
9.1.4 Sanofi Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Polio Vaccine Product and Services
9.2.4 GSK Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Bibcol
9.3.1 Bibcol Details
9.3.2 Bibcol Major Business
9.3.3 Bibcol Polio Vaccine Product and Services
9.3.4 Bibcol Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bibcol Recent Developments/Updates
9.3.6 Bibcol Competitive Strengths & Weaknesses
9.4 Serum Institute (Bilthoven Biologicals)
9.4.1 Serum Institute (Bilthoven Biologicals) Details
9.4.2 Serum Institute (Bilthoven Biologicals) Major Business
9.4.3 Serum Institute (Bilthoven Biologicals) Polio Vaccine Product and Services
9.4.4 Serum Institute (Bilthoven Biologicals) Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
9.4.6 Serum Institute (Bilthoven Biologicals) Competitive Strengths & Weaknesses
9.5 Tiantan Biological
9.5.1 Tiantan Biological Details
9.5.2 Tiantan Biological Major Business
9.5.3 Tiantan Biological Polio Vaccine Product and Services
9.5.4 Tiantan Biological Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Tiantan Biological Recent Developments/Updates
9.5.6 Tiantan Biological Competitive Strengths & Weaknesses
9.6 IMBCA
9.6.1 IMBCA Details
9.6.2 IMBCA Major Business
9.6.3 IMBCA Polio Vaccine Product and Services
9.6.4 IMBCA Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 IMBCA Recent Developments/Updates
9.6.6 IMBCA Competitive Strengths & Weaknesses
9.7 Panacea Biotec Ltd
9.7.1 Panacea Biotec Ltd Details
9.7.2 Panacea Biotec Ltd Major Business
9.7.3 Panacea Biotec Ltd Polio Vaccine Product and Services
9.7.4 Panacea Biotec Ltd Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Ltd Recent Developments/Updates
9.7.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
9.8 Bio-Med
9.8.1 Bio-Med Details
9.8.2 Bio-Med Major Business
9.8.3 Bio-Med Polio Vaccine Product and Services
9.8.4 Bio-Med Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bio-Med Recent Developments/Updates
9.8.6 Bio-Med Competitive Strengths & Weaknesses
9.9 Halfkin Bio-Pharmaceuticals
9.9.1 Halfkin Bio-Pharmaceuticals Details
9.9.2 Halfkin Bio-Pharmaceuticals Major Business
9.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
9.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
9.9.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Polio Vaccine Industry Chain
10.2 Polio Vaccine Upstream Analysis
10.2.1 Polio Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Polio Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Polio Vaccine Production Mode
10.6 Polio Vaccine Procurement Model
10.7 Polio Vaccine Industry Sales Model and Sales Channels
10.7.1 Polio Vaccine Sales Model
10.7.2 Polio Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Polio Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Polio Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Polio Vaccine Major Market Trends
Table 13. World Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Polio Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Polio Vaccine Producers in 2025
Table 18. World Polio Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Polio Vaccine Producers in 2025
Table 20. World Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Polio Vaccine Company Evaluation Quadrant
Table 22. World Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Polio Vaccine Production Site of Key Manufacturer
Table 24. Polio Vaccine Market: Company Product Type Footprint
Table 25. Polio Vaccine Market: Company Product Application Footprint
Table 26. Polio Vaccine Competitive Factors
Table 27. Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Polio Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Polio Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Polio Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Polio Vaccine Production Market Share (2021-2026)
Table 47. World Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Polio Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Polio Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Polio Vaccine Production by Virus Type (2021-2026) & (K Dose)
Table 56. World Polio Vaccine Production by Virus Type (2027-2032) & (K Dose)
Table 57. World Polio Vaccine Production Value by Virus Type (2021-2026) & (USD Million)
Table 58. World Polio Vaccine Production Value by Virus Type (2027-2032) & (USD Million)
Table 59. World Polio Vaccine Average Price by Virus Type (2021-2026) & (US$/Dose)
Table 60. World Polio Vaccine Average Price by Virus Type (2027-2032) & (US$/Dose)
Table 61. World Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Polio Vaccine Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World Polio Vaccine Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World Polio Vaccine Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Polio Vaccine Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Polio Vaccine Average Price by Dosage Form (2021-2026) & (US$/Dose)
Table 67. World Polio Vaccine Average Price by Dosage Form (2027-2032) & (US$/Dose)
Table 68. World Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Polio Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Polio Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Polio Vaccine Product and Services
Table 78. Sanofi Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Polio Vaccine Product and Services
Table 84. GSK Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Bibcol Basic Information, Manufacturing Base and Competitors
Table 88. Bibcol Major Business
Table 89. Bibcol Polio Vaccine Product and Services
Table 90. Bibcol Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bibcol Recent Developments/Updates
Table 92. Bibcol Competitive Strengths & Weaknesses
Table 93. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 94. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 95. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Product and Services
Table 96. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 98. Serum?Institute?(Bilthoven?Biologicals) Competitive Strengths & Weaknesses
Table 99. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 100. Tiantan Biological Major Business
Table 101. Tiantan Biological Polio Vaccine Product and Services
Table 102. Tiantan Biological Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. Tiantan Biological Competitive Strengths & Weaknesses
Table 105. IMBCA Basic Information, Manufacturing Base and Competitors
Table 106. IMBCA Major Business
Table 107. IMBCA Polio Vaccine Product and Services
Table 108. IMBCA Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. IMBCA Recent Developments/Updates
Table 110. IMBCA Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Ltd Major Business
Table 113. Panacea Biotec Ltd Polio Vaccine Product and Services
Table 114. Panacea Biotec Ltd Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Ltd Recent Developments/Updates
Table 116. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 117. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 118. Bio-Med Major Business
Table 119. Bio-Med Polio Vaccine Product and Services
Table 120. Bio-Med Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Med Recent Developments/Updates
Table 122. Bio-Med Competitive Strengths & Weaknesses
Table 123. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Halfkin Bio-Pharmaceuticals Major Business
Table 125. Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
Table 126. Halfkin Bio-Pharmaceuticals Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 128. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 129. Global Key Players of Polio Vaccine Upstream (Raw Materials)
Table 130. Global Polio Vaccine Typical Customers
Table 131. Polio Vaccine Typical Distributors
Table 1. World Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Polio Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Polio Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Polio Vaccine Major Market Trends
Table 13. World Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Polio Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Polio Vaccine Producers in 2025
Table 18. World Polio Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Polio Vaccine Producers in 2025
Table 20. World Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Polio Vaccine Company Evaluation Quadrant
Table 22. World Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Polio Vaccine Production Site of Key Manufacturer
Table 24. Polio Vaccine Market: Company Product Type Footprint
Table 25. Polio Vaccine Market: Company Product Application Footprint
Table 26. Polio Vaccine Competitive Factors
Table 27. Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Polio Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Polio Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Polio Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Polio Vaccine Production Market Share (2021-2026)
Table 47. World Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Polio Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Polio Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Polio Vaccine Production by Virus Type (2021-2026) & (K Dose)
Table 56. World Polio Vaccine Production by Virus Type (2027-2032) & (K Dose)
Table 57. World Polio Vaccine Production Value by Virus Type (2021-2026) & (USD Million)
Table 58. World Polio Vaccine Production Value by Virus Type (2027-2032) & (USD Million)
Table 59. World Polio Vaccine Average Price by Virus Type (2021-2026) & (US$/Dose)
Table 60. World Polio Vaccine Average Price by Virus Type (2027-2032) & (US$/Dose)
Table 61. World Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Polio Vaccine Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World Polio Vaccine Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World Polio Vaccine Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Polio Vaccine Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Polio Vaccine Average Price by Dosage Form (2021-2026) & (US$/Dose)
Table 67. World Polio Vaccine Average Price by Dosage Form (2027-2032) & (US$/Dose)
Table 68. World Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Polio Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Polio Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Polio Vaccine Product and Services
Table 78. Sanofi Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Polio Vaccine Product and Services
Table 84. GSK Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Bibcol Basic Information, Manufacturing Base and Competitors
Table 88. Bibcol Major Business
Table 89. Bibcol Polio Vaccine Product and Services
Table 90. Bibcol Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bibcol Recent Developments/Updates
Table 92. Bibcol Competitive Strengths & Weaknesses
Table 93. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 94. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 95. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Product and Services
Table 96. Serum?Institute?(Bilthoven?Biologicals) Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 98. Serum?Institute?(Bilthoven?Biologicals) Competitive Strengths & Weaknesses
Table 99. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 100. Tiantan Biological Major Business
Table 101. Tiantan Biological Polio Vaccine Product and Services
Table 102. Tiantan Biological Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. Tiantan Biological Competitive Strengths & Weaknesses
Table 105. IMBCA Basic Information, Manufacturing Base and Competitors
Table 106. IMBCA Major Business
Table 107. IMBCA Polio Vaccine Product and Services
Table 108. IMBCA Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. IMBCA Recent Developments/Updates
Table 110. IMBCA Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Ltd Major Business
Table 113. Panacea Biotec Ltd Polio Vaccine Product and Services
Table 114. Panacea Biotec Ltd Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Ltd Recent Developments/Updates
Table 116. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 117. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 118. Bio-Med Major Business
Table 119. Bio-Med Polio Vaccine Product and Services
Table 120. Bio-Med Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Med Recent Developments/Updates
Table 122. Bio-Med Competitive Strengths & Weaknesses
Table 123. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Halfkin Bio-Pharmaceuticals Major Business
Table 125. Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
Table 126. Halfkin Bio-Pharmaceuticals Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 128. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 129. Global Key Players of Polio Vaccine Upstream (Raw Materials)
Table 130. Global Polio Vaccine Typical Customers
Table 131. Polio Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Polio Vaccine Picture
Figure 2. World Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Polio Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Polio Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Polio Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Polio Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Polio Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Polio Vaccine Production (2021-2032) & (K Dose)
Figure 12. India Polio Vaccine Production (2021-2032) & (K Dose)
Figure 13. Polio Vaccine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. World Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 17. United States Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. China Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Europe Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. Japan Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. India Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Polio Vaccine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Polio Vaccine Markets in 2025
Figure 27. United States VS China: Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Polio Vaccine Production Market Share 2025
Figure 31. China Based Manufacturers Polio Vaccine Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Polio Vaccine Production Market Share 2025
Figure 33. World Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Polio Vaccine Production Value Market Share by Type in 2025
Figure 35. Inactivated Polio Vaccine (IPV)
Figure 36. Oral Polio Vaccine (OPV)
Figure 37. World Polio Vaccine Production Market Share by Type (2021-2032)
Figure 38. World Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 39. World Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 40. World Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World Polio Vaccine Production Value Market Share by Virus Type in 2025
Figure 42. Monovalent
Figure 43. Bivalent
Figure 44. Trivalent
Figure 45. World Polio Vaccine Production Market Share by Virus Type (2021-2032)
Figure 46. World Polio Vaccine Production Value Market Share by Virus Type (2021-2032)
Figure 47. World Polio Vaccine Average Price by Virus Type (2021-2032) & (US$/Dose)
Figure 48. World Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 49. World Polio Vaccine Production Value Market Share by Dosage Form in 2025
Figure 50. Oral Drops
Figure 51. Sugar Pill
Figure 52. Injection
Figure 53. World Polio Vaccine Production Market Share by Dosage Form (2021-2032)
Figure 54. World Polio Vaccine Production Value Market Share by Dosage Form (2021-2032)
Figure 55. World Polio Vaccine Average Price by Dosage Form (2021-2032) & (US$/Dose)
Figure 56. World Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Polio Vaccine Production Value Market Share by Application in 2025
Figure 58. Public
Figure 59. Private
Figure 60. World Polio Vaccine Production Market Share by Application (2021-2032)
Figure 61. World Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 62. World Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 63. Polio Vaccine Industry Chain
Figure 64. Polio Vaccine Procurement Model
Figure 65. Polio Vaccine Sales Model
Figure 66. Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Polio Vaccine Picture
Figure 2. World Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Polio Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Polio Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Polio Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Polio Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Polio Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Polio Vaccine Production (2021-2032) & (K Dose)
Figure 12. India Polio Vaccine Production (2021-2032) & (K Dose)
Figure 13. Polio Vaccine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. World Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 17. United States Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. China Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Europe Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. Japan Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. India Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Polio Vaccine Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Polio Vaccine Markets in 2025
Figure 27. United States VS China: Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Polio Vaccine Production Market Share 2025
Figure 31. China Based Manufacturers Polio Vaccine Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Polio Vaccine Production Market Share 2025
Figure 33. World Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Polio Vaccine Production Value Market Share by Type in 2025
Figure 35. Inactivated Polio Vaccine (IPV)
Figure 36. Oral Polio Vaccine (OPV)
Figure 37. World Polio Vaccine Production Market Share by Type (2021-2032)
Figure 38. World Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 39. World Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 40. World Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World Polio Vaccine Production Value Market Share by Virus Type in 2025
Figure 42. Monovalent
Figure 43. Bivalent
Figure 44. Trivalent
Figure 45. World Polio Vaccine Production Market Share by Virus Type (2021-2032)
Figure 46. World Polio Vaccine Production Value Market Share by Virus Type (2021-2032)
Figure 47. World Polio Vaccine Average Price by Virus Type (2021-2032) & (US$/Dose)
Figure 48. World Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 49. World Polio Vaccine Production Value Market Share by Dosage Form in 2025
Figure 50. Oral Drops
Figure 51. Sugar Pill
Figure 52. Injection
Figure 53. World Polio Vaccine Production Market Share by Dosage Form (2021-2032)
Figure 54. World Polio Vaccine Production Value Market Share by Dosage Form (2021-2032)
Figure 55. World Polio Vaccine Average Price by Dosage Form (2021-2032) & (US$/Dose)
Figure 56. World Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Polio Vaccine Production Value Market Share by Application in 2025
Figure 58. Public
Figure 59. Private
Figure 60. World Polio Vaccine Production Market Share by Application (2021-2032)
Figure 61. World Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 62. World Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 63. Polio Vaccine Industry Chain
Figure 64. Polio Vaccine Procurement Model
Figure 65. Polio Vaccine Sales Model
Figure 66. Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
